{{Rsnum
|rsid=12987465
|Chromosome=2
|position=49487883
|Orientation=plus
|GMAF=0.4692
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 12.5 | 42.0 | 45.5
| HCB | 27.1 | 46.6 | 26.3
| JPT | 23.2 | 56.2 | 20.5
| YRI | 29.3 | 53.1 | 17.7
| ASW | 26.3 | 54.4 | 19.3
| CHB | 27.1 | 46.6 | 26.3
| CHD | 28.4 | 50.5 | 21.1
| GIH | 18.8 | 41.6 | 39.6
| LWK | 32.7 | 57.3 | 10.0
| MEX | 14.0 | 42.1 | 43.9
| MKK | 41.9 | 43.2 | 14.8
| TSI | 10.9 | 48.5 | 40.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=7E-6
  |OR=2.60
  |ORtxt=[1.424-4.737]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}